ENANTA PHARMACEUTICALS, INC (ENTA) Capital expenditures 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$12.9MFY2025 · since FY2017: $2.5M → $12.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.9M | -28.1% |
| FY2024 | $17.9M | +98.1% |
| FY2023 | $9.1M | +326.3% |
| FY2022 | $2.1M | +183.3% |
| FY2021 | $750,000 | -48.1% |
| FY2020 | $1.4M | -73.3% |
| FY2019 | $5.4M | +81.7% |
| FY2018 | $3.0M | +19.0% |
| FY2017 | $2.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice